Related Experiment Videos
Circulating tumor markers in breast cancer
C Tondini1, D F Hayes, D W Kufe
1Department of Medicine, Dana-Farber Cancer Institute, Boston, Massachusetts.
Hematology/Oncology Clinics of North America
|December 1, 1989
Summary
Tumor markers in breast cancer patients can indicate disease progression, especially in metastatic cases. While marker levels correlate with disease course, their accuracy is not absolute.
Area of Science:
- Oncology
- Biochemistry
Background:
- Breast cancer management relies on monitoring disease progression.
- Tumor markers offer a non-invasive method for tracking cancer activity.
Purpose of the Study:
- To evaluate the utility of various tumor markers in breast cancer patients.
- To assess the correlation between circulating tumor marker levels and disease course in metastatic breast cancer.
Main Methods:
- Review of tumor markers used in breast cancer patient cohorts.
- Analysis of the relationship between marker level variations and clinical disease progression.
Main Results:
- Several tumor markers were identified with potential value in metastatic breast cancer.
- Observed variations in circulating marker levels showed a good correlation with the overall disease course.
Conclusions:
- Circulating tumor markers can provide valuable insights into the management of metastatic breast cancer.
- Despite good correlation, the accuracy of tumor markers for predicting disease course has limitations.